Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NYSE: TAK) | Delayed: 20.24 -0.12 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.36 | 52 Week High | $0.55 | |||
| Open | $20.28 | 52 Week Low | $0.55 | |||
| Day High | $20.39 | P/E | N/A | |||
| Day Low | $20.17 | EPS | $-0.20 | |||
| Volume | 1,801,166 | |||||
